dr. morris on rpfs as an endpoint in prostate cancer trials
Published 11 years ago • 415 plays • Length 2:41Download video MP4
Download video MP3
Similar videos
-
1:48
dr. morris on biomarkers in prostate cancer trials
-
1:49
dr. morris on the design of the phase 3 condor trials in recurrent prostate cancer
-
0:57
dr. morris on os data with apalutamide in prostate cancer
-
1:49
dr. morris on deciding among pet tracers in prostate cancer
-
1:16
dr. morris on the promise of psma-targeted pet imaging in prostate cancer
-
1:27
dr. morris on bone biomarkers for radium-223 in prostate cancer
-
0:49
dr. dreicer on trial endpoints in prostate cancer
-
1:24
dr. morris on the next steps with bone biomarkers for prostate cancer
-
1:23
dr. morris on safety profiles of ar inhibitors in prostate cancer
-
1:30
uromigos live 2023: dr. mike morris on radioligands in prostate cancer
-
0:46
dr. morris on mechanism of action for radium-223
-
2:14
dr. morris of impact of psma-targeted imaging on clinical management of prostate cancer
-
13:32
michael morris, md discusses the future of psma-targeted therapies in apc - part 2
-
1:30
dr. morris on challenges of radium-223 treatment in prostate cancer
-
1:36
dr. morris discusses biomarkers in prostate cancer
-
1:05
dr. morris on novel approaches with radium-223 in mcrpc
-
1:00
dr. morris discusses bone metastases and pet imaging in prostate cancer
-
1:24
dr. morris on next steps for psma–targeted pet imaging in prostate cancer
-
37:01
dr. james morris: pros and cons of psa testing; robotic prostate surgery